AGP Executive Report
Last update: 1 hours agoMedicare Drug Costs: CMS will end the Medicare Part D Premium Stabilization Demonstration at the end of 2026, with many beneficiaries facing higher 2027 premiums and critics warning about affordability. Medicaid Pressure: A new study projects nearly 500,000 Medicaid enrollees with diabetes could lose coverage by 2034, hitting rural patients hardest. Medicaid Enforcement: Minnesota approved tougher sentencing for Medicaid fraud cases over $1M, with presumptive prison terms. Pharma Oversight: India’s FDA permanently cancelled Inducare Pharma’s ayurvedic manufacturing license after alleged GMP and Drugs & Cosmetics Act violations. Public Health & Access: LECOM Health opened a new Colonial Family Pharmacy in Greene Township to reduce travel for prescriptions. Policy & Work Leave: The Trump administration expanded the employer tax credit for paid family and medical leave via IRS/Treasury guidance. Care in the Field: The UAE inspected a 100-bed floating Level III trauma hospital aimed at disaster and crisis response. Clinical Innovation: Assort Health named Sunny Eappen, MD, MBA, as Chief Medical Officer to guide enterprise AI agents for patient access and care pathways.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
